Zealand's royalty deal; Khartis raises money for TED drug
💸 Khartis Therapeutics’ $50M Series B: Forge Life Science Partners, Longwood Fund, Lilly Asia Ventures and other investors backed the San Diego biotech’s latest round, which brought total funding since its ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.